These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

250 related articles for article (PubMed ID: 32363985)

  • 21. Risk and predictors of hepatocellular carcinoma for chronic hepatitis B patients with newly developed cirrhosis.
    Chien J; Liu J; Lee MH; Jen CL; Batrla-Utermann R; Lu SN; Wang LY; You SL; Yang HI; Chen CJ
    J Gastroenterol Hepatol; 2016 Dec; 31(12):1971-1977. PubMed ID: 27118149
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Assessing prognostic significance of preoperative alpha-fetoprotein in hepatitis B-associated hepatocellular carcinoma: normal is not the new normal.
    Blank S; Wang Q; Fiel MI; Luan W; Kim KW; Kadri H; Mandeli J; Hiotis SP
    Ann Surg Oncol; 2014 Mar; 21(3):986-94. PubMed ID: 24232510
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Elevated serum soluble CD14 levels in chronic HBV infection are significantly associated with HBV-related hepatocellular carcinoma.
    Li N; Zhu Q; Yang C; Li F; Zhou Z; Lv Y; Sang J; Han Q; Liu Z
    Tumour Biol; 2016 May; 37(5):6607-17. PubMed ID: 26643893
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Clinical significance of simultaneous determinations of alpha-fetoprotein and des-gamma-carboxy prothrombin in monitoring recurrence in patients with hepatocellular carcinoma.
    Aoyagi Y; Oguro M; Yanagi M; Mita Y; Suda T; Suzuki Y; Hata K; Ichii K; Asakura H
    Cancer; 1996 May; 77(9):1781-6. PubMed ID: 8646674
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Diagnostic value of serum Golgi protein 73 for HBV-related primary hepatic carcinoma.
    Gao G; Dong F; Xu X; Hu A; Hu Y
    Int J Clin Exp Pathol; 2015; 8(9):11379-85. PubMed ID: 26617863
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Combined detection of AFP-L3, GP73 and TIP30 enhances diagnostic accuracy for HBV-related cirrhosis and hepatocellular carcinoma.
    Yanming L; Yue C; Wencan C; Liangyin WU; Xijun L; Jiafeng Z; Fengping HE
    J Pak Med Assoc; 2019 Sep; 69(9):1279-1286. PubMed ID: 31511712
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Hepatocellular carcinoma screening and surveillance in 2293 chronic hepatitis B patients in an endemic area.
    Ungtrakul T; Mahidol C; Chun-On P; Laohapand C; Siripongsakun S; Worakitsitisatorn A; Vidhayakorn S; Boonchuay W; Dechma J; Sornsamdang G; Soonklang K; Sriprayoon T; Tanwandee T; Auewarakul CU
    World J Gastroenterol; 2016 Sep; 22(34):7806-12. PubMed ID: 27678364
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Ascites and alpha-fetoprotein improve prognostic performance of Barcelona Clinic Liver Cancer staging.
    Gomaa AI; Al-Khatib A; Abdel-Razek W; Hashim MS; Waked I
    World J Gastroenterol; 2015 May; 21(18):5654-62. PubMed ID: 25987792
    [TBL] [Abstract][Full Text] [Related]  

  • 29. High serum hyaluronic acid and HBV viral load are main prognostic factors of local recurrence after complete radiofrequency ablation of hepatitis B-related small hepatocellular carcinoma.
    Xia F; Lai EC; Lau WY; Ma K; Li X; Bie P; Qian C
    Ann Surg Oncol; 2012 Apr; 19(4):1284-91. PubMed ID: 21913016
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Heterochronous development of intrahepatic cholangiocellular carcinoma following hepatocellular carcinoma in a hepatitis B virus carrier.
    Shiozawa K; Ishii K; Mori T; Takamura N; Ikehara T; Shinohara M; Kawafune T; Sumino Y; Nonaka H
    Intern Med; 2001 Jul; 40(7):624-30. PubMed ID: 11506304
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Utility of alpha-fetoprotein (AFP) in the screening of patients with virus-related chronic liver disease: does different viral etiology influence AFP levels in HCC? A study in 350 western patients.
    Cedrone A; Covino M; Caturelli E; Pompili M; Lorenzelli G; Villani MR; Valle D; Sperandeo M; Rapaccini GL; Gasbarrini G
    Hepatogastroenterology; 2000; 47(36):1654-8. PubMed ID: 11149026
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Serum SOX11 promoter methylation is a novel biomarker for the diagnosis of Hepatitis B virus-related hepatocellular carcinoma.
    Teng Y; Fan YC; Mu NN; Zhao J; Sun FK; Wang K
    Neoplasma; 2016; 63(3):419-26. PubMed ID: 26925788
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Molecular analysis of Hepatitis B virus sub-genotypes and incidence of preS1/preS2 region mutations in HBV-infected Egyptian patients from Mansoura.
    El-Mowafy M; Elgaml A; El-Mesery M; Elegezy M
    J Med Virol; 2017 Sep; 89(9):1559-1566. PubMed ID: 28390175
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Reduction of double-stranded RNA-activated protein kinase in hepatocellular carcinoma associated with hepatitis B virus.
    Chen GG; Lai PB; Ho RL; Chan PK; Xu H; Wong J; Lau WY
    J Med Virol; 2004 Jun; 73(2):187-94. PubMed ID: 15122791
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Droplet digital PCR detects high rate of TP53 R249S mutants in cell-free DNA of middle African patients with hepatocellular carcinoma.
    Marchio A; Amougou Atsama M; Béré A; Komas NP; Noah Noah D; Atangana PJA; Camengo-Police SM; Njouom R; Bekondi C; Pineau P
    Clin Exp Med; 2018 Aug; 18(3):421-431. PubMed ID: 29749584
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Effects of radiofrequency ablation combined with transarterial chemoembolization and antiviral therapy on the prognosis and quality of life in primary chronic HBV-related liver cancer.
    Lu B; Zhu L; Wang X; Zhong L; Cheng Y; Fan J; Yu L
    J BUON; 2019; 24(5):1979-1984. PubMed ID: 31786864
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Improved Performance of Serum Alpha-Fetoprotein for Hepatocellular Carcinoma Diagnosis in HCV Cirrhosis with Normal Alanine Transaminase.
    Yang JD; Dai J; Singal AG; Gopal P; Addissie BD; Nguyen MH; Befeler AS; Reddy KR; Schwartz M; Harnois DM; Yamada H; Gores GJ; Feng Z; Marrero JA; Roberts LR
    Cancer Epidemiol Biomarkers Prev; 2017 Jul; 26(7):1085-1092. PubMed ID: 28258053
    [No Abstract]   [Full Text] [Related]  

  • 38. Impact of occult hepatitis B virus infection and prior hepatitis B virus infection on development of hepatocellular carcinoma in patients with liver cirrhosis due to hepatitis C virus.
    Adachi S; Shibuya A; Miura Y; Takeuchi A; Nakazawa T; Saigenji K
    Scand J Gastroenterol; 2008; 43(7):849-56. PubMed ID: 18584524
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Post-ablation des-gamma-carboxy prothrombin level predicts prognosis in hepatitis B-related hepatocellular carcinoma.
    Lee S; Rhim H; Kim YS; Kang TW; Song KD
    Liver Int; 2016 Apr; 36(4):580-7. PubMed ID: 26503910
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Serum DKK1 as a protein biomarker for the diagnosis of hepatocellular carcinoma: a large-scale, multicentre study.
    Shen Q; Fan J; Yang XR; Tan Y; Zhao W; Xu Y; Wang N; Niu Y; Wu Z; Zhou J; Qiu SJ; Shi YH; Yu B; Tang N; Chu W; Wang M; Wu J; Zhang Z; Yang S; Gu J; Wang H; Qin W
    Lancet Oncol; 2012 Aug; 13(8):817-26. PubMed ID: 22738799
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 13.